NCT06767514

Brief Summary

Clinical study of ivonescimab for first-line treatment of metastatic NSCLC patients with high PD-L1. Evaluating overall survival and progression free survival.

Trial Health

88
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
780

participants targeted

Target at P75+ for phase_3 nonsmall-cell-lung-cancer

Timeline
37mo left

Started Feb 2025

Geographic Reach
16 countries

202 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Feb 2025Jun 2029

First Submitted

Initial submission to the registry

January 3, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 10, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

February 27, 2025

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2028

Expected
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2029

Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

3.1 years

First QC Date

January 3, 2025

Last Update Submit

February 20, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Overall Survival (OS)

    Up to approximately 36 months

  • Progression free survival (PFS)

    Up to approximately 36 months

Secondary Outcomes (4)

  • Objective response rate (ORR)

    Up to approximately 36 months

  • Disease control rate ( DCR)

    Up to approximately 36 months

  • Duration of response (DoR)

    Up to approximately 36 months

  • Adverse Events (AE): incidence and severity of adverse events (AEs) and clinically significant abnormal laboratory test results

    [Time Frame: From the subject signs the ICF to 30 days (AE) and 90 days (SAE related to ivonescimab/pembrolizumab ) after the last dose of study treatment or initiation of other anticancer therapy, whichever occurs first, Up to approximately 24 months.

Study Arms (2)

Arm A - Ivonescimab

EXPERIMENTAL

Subject will receive ivonescimab as an IV injection

Biological: Ivonescimab Injection

Arm B - Pembrolizumab

ACTIVE COMPARATOR

Subject will receive pembrolizumab as an IV injection

Biological: Pembrolizumab Injection

Interventions

Subject will receive ivonescimab as an IV injection

Arm A - Ivonescimab

Subject will receive Pembrolizumab as an IV injection

Arm B - Pembrolizumab

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years old at the time of enrollment
  • Eastern Cooperative Oncology Group (ECOG) performance status score of 0 - 1
  • Expected life expectancy ≥ 3 months
  • Metastatic (Stage IV) NSCLC
  • Histologically or cytologically confirmed squamous or non-squamous NSCLC
  • Tumor demonstrates high PD-L1 expression ( TPS\>50%) based on a 22C3 immunohistochemistry ( IHC) clinical assay approved / cleared by local health authorities.
  • At least one measurable noncerebral lesion according to RECIST 1.1
  • No prior systemic treatment for metastatic NSCLC.

You may not qualify if:

  • Histologic or cytopathologic evidence of the presence of small cell lung carcinoma for which first-line approved therapies are indicated. For patients with non-squamous histology, actionable driver mutation testing results are required before randomization.
  • Has received any prior therapy for NSCLC in the metastatic setting.
  • Concurrent enrollment in another clinical study, unless patient is enrolled in a non-interventional clinical study or is completing survival follow -up.
  • Known actionable genomic alterations for which first-line approved therapies are indicated
  • Symptomatic CNS metastases, CNS metastasis ≥ 1.5 cm, CNS radiation within 7 days prior to randomization, potential need for CNS radiation within the first cycle, or leptomeningeal disease
  • Other prior malignancy (including previously treated NSCLC) unless the patient has undergone curative therapy with no evidence of recurrence of the disease for 3 years prior to randomization
  • Active autoimmune or lung disease requiring systemic therapy
  • Has pre-existing peripheral neuropathy that is ≥ Grade 2 by CTCAE version 5
  • Severe infection within 4 weeks prior to randomization
  • Major surgical procedures or serious trauma within 4 weeks prior to randomization
  • History of noninfectious pneumonia requiring systemic corticosteroids, or current interstitial lung disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (202)

Clinical Study Site

Chandler, Arizona, 85224, United States

RECRUITING

Clinical Study Site

Phoenix, Arizona, 85006, United States

RECRUITING

Clinical Study Site

Hot Springs, Arkansas, 71913, United States

RECRUITING

Clinical Study Site

Cerritos, California, 90703, United States

RECRUITING

Clinical Study Site

Glendale, California, 91204, United States

RECRUITING

Clinical Study Site

Irvine, California, 92612, United States

RECRUITING

Clinical Study Site

Los Angeles, California, 90067, United States

RECRUITING

Clinical Study Site

Mountain View, California, 94040, United States

RECRUITING

Clinical Study Site

Murrieta, California, 92562, United States

RECRUITING

Clinical Study Site

Newport Beach, California, 92663, United States

RECRUITING

Clinical Study Site

Roseville, California, 95661, United States

RECRUITING

Clinical Study Site

Sacramento, California, 95816, United States

RECRUITING

Clinical Study Site

San Diego, California, 92123, United States

RECRUITING

Clinical Study Site

San Francisco, California, 94115, United States

RECRUITING

Clinical Study Site

Santa Ana, California, 92705, United States

RECRUITING

Clinical Study Site

Whittier, California, 90602, United States

RECRUITING

Clinical Study Site

Aurora, Colorado, 80045, United States

RECRUITING

Clinical Study Site

Grand Junction, Colorado, 81505, United States

RECRUITING

Clinical Study Site

Greeley, Colorado, 80631, United States

RECRUITING

Clinical Study Site

Lone Tree, Colorado, 80124, United States

RECRUITING

Clinical Study Site

Loveland, Colorado, 80538, United States

RECRUITING

Clinical Study Site

Fort Lauderdale, Florida, 33317, United States

RECRUITING

Clinical Study Site

Hialeah, Florida, 33013, United States

RECRUITING

Clinical Study Site

Jacksonville, Florida, 32256, United States

RECRUITING

Clinical Study Site

Miami, Florida, 33155, United States

RECRUITING

Clinical Study Site

North Venice, Florida, 34275, United States

RECRUITING

Clinical Study Site

Orlando, Florida, 32822, United States

RECRUITING

Clinical Study Site

Pensacola, Florida, 32504, United States

RECRUITING

Clinical Study Site

Plantation, Florida, 33322, United States

RECRUITING

Clinical Study Site

Plantation, Florida, 33323, United States

RECRUITING

Clinical Study Site

Tallahassee, Florida, 32308, United States

RECRUITING

Clinical Study Site

Tamarac, Florida, 33321, United States

RECRUITING

Clinical Study Site

West Palm Beach, Florida, 33401, United States

RECRUITING

Clinical Study Site

Atlanta, Georgia, 30318, United States

RECRUITING

Clinical Study Site

Macon, Georgia, 30318, United States

RECRUITING

Clinical Study Site

Macon, Georgia, 31210, United States

RECRUITING

Clinical Study Site

Carterville, Illinois, 62918, United States

RECRUITING

Clinical Study Site

Indianapolis, Indiana, 46237, United States

RECRUITING

Clinical Study Site

Waukee, Iowa, 50263, United States

RECRUITING

Clinical Study Site

Lexington, Kentucky, 40503, United States

RECRUITING

Clinical Study Site

Covington, Louisiana, 70433, United States

RECRUITING

Clinical Study Site

Baltimore, Maryland, 21229, United States

RECRUITING

Clinical Study Site

Boston, Massachusetts, 02215, United States

RECRUITING

Clinical Study Site

Milton, Massachusetts, 02186, United States

RECRUITING

Clinical Study Site

Worcester, Massachusetts, 01655, United States

RECRUITING

Clinical Study Sites

Detroit, Michigan, 48202, United States

RECRUITING

Clinical Study Site

Detroit, Michigan, 48202, United States

RECRUITING

Clinical Study Site

Lansing, Michigan, 48910, United States

RECRUITING

Clinical Study Site

Minneapolis, Minnesota, 55455, United States

RECRUITING

Clinical Study Site

Saint Louis Park, Minnesota, 55426, United States

RECRUITING

Clinical Study Site

Saint Paul, Minnesota, 55101, United States

RECRUITING

Clinical Study Site

Hattiesburg, Mississippi, 39401, United States

RECRUITING

Clinical Study Site

Kansas City, Missouri, 64132, United States

RECRUITING

Clinical Study Site

St Louis, Missouri, 63128, United States

RECRUITING

Clinical Study Site

Lebanon, New Hampshire, 03756, United States

RECRUITING

Clinical Study Site

Basking Ridge, New Jersey, 07920, United States

RECRUITING

Clinical Study Site

Middletown, New Jersey, 07748, United States

RECRUITING

Clinical Study Site

Montvale, New Jersey, 07645, United States

RECRUITING

Clinical Study Site

Mullica Hill, New Jersey, 08062, United States

RECRUITING

Clinical Study Site

New Brunswick, New Jersey, 08901, United States

RECRUITING

Clinical Study Site

Glen Falls, New York, 12801, United States

RECRUITING

Clinical Study Site

Harrison, New York, 10604, United States

RECRUITING

Clinical Study Site

New York, New York, 10065, United States

RECRUITING

Clinical Study Site

Syracuse, New York, 13210, United States

RECRUITING

Clinical Study Site

Uniondale, New York, 11553, United States

RECRUITING

Clinical Study Site

Chapel Hill, North Carolina, 27592, United States

RECRUITING

Clinical Study Site

Columbus, Ohio, 43219, United States

RECRUITING

Clinical Study Sites

Lebanon, Ohio, 45036, United States

RECRUITING

Clinical Study Site

Oklahoma City, Oklahoma, 73102, United States

RECRUITING

Clinical Study Site

Eugene, Oregon, 97401, United States

RECRUITING

Clinical Study Site

Portland, Oregon, 97239, United States

RECRUITING

Clinical Study Site

Philadelphia, Pennsylvania, 19111, United States

RECRUITING

Clinical Study Site

Pittsburgh, Pennsylvania, 15232, United States

RECRUITING

Clinical Study Site

Nashville, Tennessee, 37235, United States

RECRUITING

Clinical Study Site

Abilene, Texas, 79601, United States

RECRUITING

Clinical Study Site

Austin, Texas, 78745, United States

RECRUITING

Clinical Study Site

Dallas, Texas, 75246, United States

RECRUITING

Clinical Study Site

Forth Worth, Texas, 76104, United States

RECRUITING

Clinical Study Site

Houston, Texas, 77030, United States

RECRUITING

Clinical Study Site

Tyler, Texas, 75708, United States

RECRUITING

Clinical Study Site

Webster, Texas, 77598, United States

RECRUITING

Clinical Study Site

Salt Lake City, Utah, 84106, United States

RECRUITING

Clinical Study Site

Blacksburg, Virginia, 24060, United States

RECRUITING

Clinical Study Site

Charlottesville, Virginia, 22908, United States

RECRUITING

Clinical Study Site

Fairfax, Virginia, 22031, United States

RECRUITING

Clinical Study Site

Richmond, Virginia, 23229, United States

RECRUITING

Clinical Study Site

Richmond, Virginia, 23298, United States

RECRUITING

Clinical Study Site

Seattle, Washington, 98109, United States

RECRUITING

Clinical Study Site

Vancouver, Washington, 98684, United States

RECRUITING

Clinical Study Site

Edmonton, Alberta, T6G 1Z2, Canada

RECRUITING

Clinical Study Site

London, Ontario, N6A 5W9, Canada

RECRUITING

Clinical Study Site

Montreal, Quebec, H3T 1E2, Canada

RECRUITING

Clinical Study Site

Montreal, H3T 1E2, Canada

RECRUITING

Clinical Study Site

Fuzhou, Fujian, China

RECRUITING

Clinical Study Site

Guangzhou, Guangdong, China

RECRUITING

Clinical Study Site

Haikou, Hainan, China

RECRUITING

Clinical Study Site

Harbin, Heilongjiang, 150081, China

RECRUITING

Clinical Site Study

Changzhou, Jiangsu, China

RECRUITING

Clinical Study Site

Ganzhou, Jiangxi, China

RECRUITING

Clinical Study Site

Nanchang, Jiangxi, China

RECRUITING

Clinical Study Site

Tai’an, Shandong, China

RECRUITING

Clinical Study Site

Weifang, Shandong, China

RECRUITING

Clinical Study Site

Shanghai, Shanghai Municipality, China

RECRUITING

Clinical Study Site

Kunming, Yunnan, China

RECRUITING

Clinical Study Site

Hangzhou, Zhejiang, China

RECRUITING

Clinical Study Site

Taizhou, Zhejiang, China

RECRUITING

Clinical Site Study

Wenzhou, Zhejiang, China

RECRUITING

Clinical Study Site

Changchun, China

RECRUITING

Clinical Study Site

Guangzhou, China

RECRUITING

Clinical Study Site

Xi'an, China

RECRUITING

Clinical Study Site

Nantes, Pays de Loire, 44277, France

RECRUITING

Clinical Study Site

Brest, 29200, France

RECRUITING

Clinical Study Site

Créteil, 94010, France

RECRUITING

Clinical Study Site

Lyon, 69008, France

RECRUITING

Clinical Study Site

Marseille, 13000, France

RECRUITING

Clinical Study Site

Paris, 75020, France

RECRUITING

Clinical Study Site

Rennes, 35033, France

RECRUITING

Clinical Study Site

Villejuif, 94800, France

RECRUITING

Clinical Study Site

Chemnitz, 91116, Germany

RECRUITING

Clinical Study Site

Gauting, 82131, Germany

RECRUITING

Clinical Study Site

Giesen, 35392, Germany

RECRUITING

Clinical Study Site

Karlsruhe, 76137, Germany

RECRUITING

Clinical Study Site

Minden, 32429, Germany

RECRUITING

Clinical Study Site

Moers, 47441, Germany

RECRUITING

Clinical Study Site

Möser, 47441, Germany

RECRUITING

Clinical Study Site

Athens, 15562, Greece

RECRUITING

Clinical Study Site

Rio, 26504, Greece

RECRUITING

Clinical Study Site

Thessaloniki, 546 22, Greece

RECRUITING

Clinical Study Site

Budapest, 01121, Hungary

RECRUITING

Clinical Study Site

Kecskemét, 6000, Hungary

RECRUITING

Clinical Study Site

Bari, 70124, Italy

RECRUITING

Clinical Study Site

Milan, 20037, Italy

RECRUITING

Clinical Study Site

Milan, 20141, Italy

RECRUITING

Clinical Study Site

Orbassano, 10043, Italy

RECRUITING

Clinical Study Site

Parma, 43126, Italy

RECRUITING

Clinical Study Site

Roma, 00144, Italy

RECRUITING

Clinical Study Site

Asahikawa, Hokkaido, 078-8510, Japan

RECRUITING

Clinical Study Site

Nishinomiya, Hyōgo, 663-8501, Japan

RECRUITING

Clinical Study Site

Matsusaka, Mie-ken, 515-8544, Japan

RECRUITING

Clinical Study Site

Sendai, Miyagi, 980-8574, Japan

RECRUITING

Clinical Study Site

Omura-shi, Nagasaki, 856-8562, Japan

RECRUITING

Clinical Study Site

Hirakata, Osaka, 573-1191, Japan

RECRUITING

Clinical Study Site

Osaka, Osaka, 541-8567, Japan

RECRUITING

Clinical Study Site

Hidaka, Saitama, 350-1298, Japan

RECRUITING

Clinical Study Site

Shimotsuke, Tochigi, 329-0498, Japan

RECRUITING

Clinical Study Site

Bunkyō-Ku, Tokyo, 113-8677, Japan

RECRUITING

Clinical Study Site

Koto-Ku, Tokyo, 135-8550, Japan

RECRUITING

Clinical Study Site

Wakayama, Wakayama, 641-8510, Japan

RECRUITING

Clinical Study Site

Kanazawa, 920-8641, Japan

RECRUITING

Clinical Study Site

Kumamoto, 861-4193, Japan

RECRUITING

Clinical Study Site

Kurume, 830-0011, Japan

RECRUITING

Clinical Study Site

Nagoya, 460-0001, Japan

RECRUITING

Clinical Study Site

Okayama, 700-8558, Japan

RECRUITING

Clinical Study Site

Sakai, 591-8555, Japan

RECRUITING

Clinical Study Site

Tokyo, 104-0045, Japan

RECRUITING

Clinical Study Site

Guadalajara, 44670, Mexico

RECRUITING

Clinical Study Site

Mexico City, 06700, Mexico

RECRUITING

Clinical Study Site

Monterrey, 64710, Mexico

RECRUITING

Clinical Study Site

Veracruz, 91900, Mexico

RECRUITING

Clinical Study Site

Gdansk, 80214, Poland

RECRUITING

Clinical Study Site

Lodz, 93338, Poland

RECRUITING

Clinical Study Site

Lublin, 20064, Poland

RECRUITING

Clinical Study Site

Poznan, 60-693, Poland

RECRUITING

Clinical Study Site

Skorzewo, 60185, Poland

RECRUITING

Clinical Study Site

Braga, 4710-243, Portugal

RECRUITING

Clinical Study Site

Coimbra, 3020-479, Portugal

RECRUITING

Clinical Study Site

Faro, 8000-386, Portugal

RECRUITING

Clinical Study Site

Porto, 4099-001, Portugal

RECRUITING

Clinical Study Site

Suceagu, Cluj, 407062, Romania

RECRUITING

Clinical Study Site

Baia Mare, 430031, Romania

RECRUITING

Clinical Study Site

Bucharest, 22328, Romania

RECRUITING

Clinical Study Site

Cluj-Napoca, 407062, Romania

RECRUITING

Clinical Study Site

Cluj-Napoca, 407280, Romania

RECRUITING

Clinical Study Site

Craiova, 200542, Romania

RECRUITING

Clinical Study Site

Iași, 700106, Romania

RECRUITING

Clinical Study Site

Ovidiu, 905900, Romania

RECRUITING

Clinical Study Site

Timișoara, 300166, Romania

RECRUITING

Clinical Study Site

Belgrade, 11040, Serbia

RECRUITING

Clinical Study Site

Belgrade, 11080, Serbia

RECRUITING

Clinical Study Site

Kragujevac, 34000, Serbia

RECRUITING

Clinical Study Site

Novi Sad, 21204, Serbia

RECRUITING

Clinical Study Site

Badajoz, 06080, Spain

RECRUITING

Clinical Study Site

Badalona, 08916, Spain

RECRUITING

Clinical Study Site

Barcelona, 08003, Spain

RECRUITING

Clinical Study Site

Girona, 17007, Spain

RECRUITING

Clinical Study Site

Las Palmas, 35016, Spain

RECRUITING

Clinical Study Site

Lugo, 27002, Spain

RECRUITING

Clinical Study Site

Madrid, 28040, Spain

RECRUITING

Clinical Study Site

Málaga, 29011, Spain

RECRUITING

Clinical Study Site

Seville, 41014, Spain

RECRUITING

Clinical Study Site

Valencia, 46026, Spain

RECRUITING

Clinical Study Site

Zaragoza, 50009, Spain

RECRUITING

Clinical Study Site

Adana, 01140, Turkey (Türkiye)

RECRUITING

Clinical Study Site

Ankara, 06520, Turkey (Türkiye)

RECRUITING

Clinical Study Site

Antalya, 07059, Turkey (Türkiye)

RECRUITING

Clinical Study Site

Diyarbakır, 21280, Turkey (Türkiye)

RECRUITING

Clinical Study Site

Gaziantep, 27060, Turkey (Türkiye)

RECRUITING

Clinical Study Site

Istanbul, 34460, Turkey (Türkiye)

RECRUITING

Clinical Study Site

Istanbul, 34722, Turkey (Türkiye)

RECRUITING

Clinical Study Site

İzmit, 41380, Turkey (Türkiye)

RECRUITING

Clinical Study Site

Konya, 42080, Turkey (Türkiye)

RECRUITING

Clinical Study Site

Seyhan, 07059, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

pembrolizumab

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Summit Clinical Trial Information

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 3, 2025

First Posted

January 10, 2025

Study Start

February 27, 2025

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

June 1, 2029

Last Updated

February 24, 2026

Record last verified: 2026-02

Locations